Co-Authors
This is a "connection" page, showing publications co-authored by Chenjian Gu and YueBin Zhang.
Connection Strength
0.118
-
Correction To: Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interaction. Signal Transduct Target Ther. 2021 Jun 10; 6(1):230.
Score: 0.059
-
Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein-ACE2 interaction. Signal Transduct Target Ther. 2021 05 18; 6(1):198.
Score: 0.059